Researchers from Spain have identified an immune expression signature in surgical specimens associated with disease progression for non-complete pathological responders patients treated with neo adjuvant chemo-immunotherapy, ...
Aug 8, 2022
0
17
By comparing data for the immune response to natural infection by dengue virus to data for activation of the immune system by dengue vaccines, researchers at the University of São Paulo (USP) have identified molecular markers ...
Mar 20, 2024
0
1
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease. This is the main conclusion to come out of a study ...
Apr 9, 2013
0
0
With 300-500 million people falling ill to malaria each year, this debilitating tropical disease remains a global problem. Current combination drug therapy is still generally effective, but recent signs of resistance present ...
Jun 19, 2013
0
0
A recent study by members of the Children's Oncology Group reports results of a large trial showing that children whose leukemia cells have amplification of a portion of chromosome 21 may require more aggressive treatment ...
Aug 20, 2013
0
0
Professor Shimpei Gotoh and Junior Associate Professor Kazuo Takayama teamed up in study to construct a novel in vitro culture system for alveolar and airway epithelial cells, employing a biomaterials engineering method known ...
Mar 29, 2024
0
29
A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine ...
May 21, 2013
0
0
A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal ...
May 13, 2013
0
0
An extensive analytical study conducted at the Terasaki Institute for Biomedical Innovation (TIBI) has revealed an association between favorable survival outcomes for melanoma patients and the presence of higher populations ...
May 2, 2024
0
1
Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Hematology (ASH) signal an important step forward in the development of treatment strategies ...
Dec 9, 2012
0
0
